CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
TetraGraph (TM) NMT Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06458023
NCT06458023N/ACompleted
CompareCT.gov

Train-of-four Monitoring Using the Tetragraph Neuromuscular Transmission Monitor and Comparison to Standard (Visual) Train-of-four Assessment With a Peripheral Nerve Stimulator in Patients Less Than 1 Year of Age.

Joseph D. Tobias·interventional·Posted Jun 13, 2024·Updated May 13, 2026

In Brief

A clinical study evaluating TetraGraph (TM) NMT Monitor for Surgery. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The primary objective of this study is to evaluate the efficacy of train-of-four (TOF) monitoring using the TetraGraph Neuromuscular Transmission Monitor in pediatric patients less than 1 year of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedJun 13, 2024
Enrollment StartJun 11, 2024
Primary CompletionSep 4, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.1 years ago

Interventions

TetraGraph (TM) NMT Monitordevice

TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.